Nomura Asset Management Co. Ltd. grew its holdings in Cerner (NASDAQ:CERN) by 6.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 43,700 shares of the company’s stock after purchasing an additional 2,766 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Cerner were worth $2,945,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also made changes to their positions in the company. BlackRock Inc. raised its stake in Cerner by 2.2% during the 4th quarter. BlackRock Inc. now owns 19,519,304 shares of the company’s stock worth $1,315,406,000 after buying an additional 420,942 shares during the period. Capital International Investors raised its stake in Cerner by 0.3% during the 3rd quarter. Capital International Investors now owns 4,851,296 shares of the company’s stock worth $345,994,000 after buying an additional 12,178 shares during the period. Geode Capital Management LLC raised its stake in Cerner by 2.7% during the 4th quarter. Geode Capital Management LLC now owns 3,759,894 shares of the company’s stock worth $252,916,000 after buying an additional 98,444 shares during the period. American Century Companies Inc. raised its stake in Cerner by 3.7% during the 4th quarter. American Century Companies Inc. now owns 3,204,461 shares of the company’s stock worth $215,949,000 after buying an additional 114,224 shares during the period. Finally, Legal & General Group Plc raised its stake in Cerner by 1.8% during the 3rd quarter. Legal & General Group Plc now owns 1,477,451 shares of the company’s stock worth $105,371,000 after buying an additional 25,842 shares during the period. 78.54% of the stock is currently owned by institutional investors.
In other news, Vice Chairman Clifford W. Illig sold 307,700 shares of the company’s stock in a transaction that occurred on Thursday, March 8th. The stock was sold at an average price of $64.52, for a total value of $19,852,804.00. Following the completion of the transaction, the insider now directly owns 1,229,719 shares of the company’s stock, valued at $79,341,469.88. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Jeffrey A. Townsend sold 230,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $61.94, for a total value of $14,246,200.00. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 541,800 shares of company stock valued at $34,353,860. 13.11% of the stock is currently owned by corporate insiders.
A number of research firms recently weighed in on CERN. KeyCorp dropped their price target on Cerner from $85.00 to $76.00 and set an “overweight” rating on the stock in a research note on Monday, April 2nd. Royal Bank of Canada reaffirmed a “buy” rating and set a $67.00 price target on shares of Cerner in a research note on Tuesday. BidaskClub downgraded Cerner from a “hold” rating to a “sell” rating in a research note on Wednesday, January 24th. Robert W. Baird dropped their price target on Cerner from $80.00 to $75.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 7th. Finally, Canaccord Genuity reissued a “buy” rating on shares of Cerner in a research note on Wednesday, February 7th. One analyst has rated the stock with a sell rating, twelve have issued a hold rating and ten have given a buy rating to the company. Cerner presently has an average rating of “Hold” and an average price target of $67.42.
CERN stock opened at $56.42 on Friday. The company has a market capitalization of $19,194.19, a PE ratio of 25.65, a price-to-earnings-growth ratio of 1.68 and a beta of 0.96. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.01 and a quick ratio of 2.99. Cerner has a 12-month low of $55.29 and a 12-month high of $73.86.
Cerner (NASDAQ:CERN) last released its earnings results on Tuesday, February 6th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.61 by ($0.03). The business had revenue of $1.31 billion during the quarter, compared to the consensus estimate of $1.33 billion. Cerner had a net margin of 16.86% and a return on equity of 16.82%. The business’s revenue was up 4.5% on a year-over-year basis. During the same period in the prior year, the company earned $0.61 earnings per share. analysts anticipate that Cerner will post 2.42 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: This story was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another publication, it was copied illegally and reposted in violation of US and international copyright legislation. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/04/07/cerner-co-cern-position-lifted-by-nomura-asset-management-co-ltd.html.
Cerner Company Profile
Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.